BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Diabetes

The World Journal of Diabetes (WJD) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of diabetes.  It was launched on March 15, 2010 and is published monthly (12 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage diabetologists worldwide to submit manuscripts to the WJD describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJD are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJD’s acceptance rate: 57%. Submit here >>

2018 Published Issues
9 8 7 6 5 4 3 2 1
  • Timothy R Koch, MD, Doctor, Professor, (E-mail: timothy.r.koch@medstar.net) Georgetown University School of Medicine, Department of Surgery, Center for Advanced Laparoscopic General and Bariatric Surgery, MedStar-Washington Hospital Center, Washington, DC 20010, United States
WJD is now abstracted and indexed in Emerging Sources Citation Index (Web of Science), PubMed, PubMed Central, Scopus, China National Knowledge Infrastructure (CNKI), and Superstar Journals Database.
Journal Metrics
CiteScore (2017): 4.96.
1948-9358 (online)
Effects of antidiabetic drugs on epicardial fat 
Eleni Xourgia, Athanasia Papazafiropoulou, Andreas Melidonis 
World J Diabetes 9(9):141-148. Published online Sep 15, 2018. doi: 10.4239/wjd.v9.i9.141
Basic Study
Effects of glucagon-like peptide 1 analogs in combination with insulin on myocardial infarct size in rats with type 2 diabetes mellitus 
Vladislav A Zykov, Taisiia P Tuchina, Denis A Lebedev, Irina B Krylova, Alina Y Babenko, Elvira V Kuleshova, Elena N Grineva, Alekber A Bayramov, Michael M Galagudza 
World J Diabetes 9(9):149-156. Published online Sep 15, 2018. doi: 10.4239/wjd.v9.i9.149
Case Control Study
Association of TCF7L2 mutation and atypical diabetes in a Uruguayan population 
Carolina Beloso, Jorge Souto, Matias Fabregat, Gerardo Romanelli, Gerardo Javiel, Adriana Mimbacas 
World J Diabetes 9(9):157-164. Published online Sep 15, 2018. doi: 10.4239/wjd.v9.i9.157